IL158990A0 - Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses - Google Patents

Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses

Info

Publication number
IL158990A0
IL158990A0 IL15899002A IL15899002A IL158990A0 IL 158990 A0 IL158990 A0 IL 158990A0 IL 15899002 A IL15899002 A IL 15899002A IL 15899002 A IL15899002 A IL 15899002A IL 158990 A0 IL158990 A0 IL 158990A0
Authority
IL
Israel
Prior art keywords
horses
cats
dogs
receptor antagonists
unwanted behavior
Prior art date
Application number
IL15899002A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL158990A0 publication Critical patent/IL158990A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15899002A 2001-07-20 2002-07-15 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses IL158990A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30669201P 2001-07-20 2001-07-20
PCT/IB2002/002847 WO2003009848A1 (en) 2001-07-20 2002-07-15 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses

Publications (1)

Publication Number Publication Date
IL158990A0 true IL158990A0 (en) 2004-05-12

Family

ID=23186426

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15899002A IL158990A0 (en) 2001-07-20 2002-07-15 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses

Country Status (13)

Country Link
US (1) US20030139443A1 (cg-RX-API-DMAC10.html)
EP (1) EP1411946A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005504029A (cg-RX-API-DMAC10.html)
KR (1) KR20040029375A (cg-RX-API-DMAC10.html)
CN (1) CN1529600A (cg-RX-API-DMAC10.html)
CA (1) CA2448722A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ200434A3 (cg-RX-API-DMAC10.html)
HU (1) HUP0401154A2 (cg-RX-API-DMAC10.html)
IL (1) IL158990A0 (cg-RX-API-DMAC10.html)
PL (1) PL367944A1 (cg-RX-API-DMAC10.html)
SK (1) SK252004A3 (cg-RX-API-DMAC10.html)
WO (1) WO2003009848A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200308991B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0507325A (pt) * 2004-01-30 2007-07-03 Pfizer Prod Inc antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia
HUE034099T2 (en) 2004-01-30 2018-01-29 Zoetis Services Llc Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms
CN1972937A (zh) * 2004-04-30 2007-05-30 先灵公司 神经肽受体调节剂
CN114403042A (zh) * 2021-12-13 2022-04-29 深圳先进技术研究院 一种大动物焦虑症动物模型

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BR9206073A (pt) * 1991-05-31 1994-12-06 Pfizer Derivados de quinuclidina
SK282203B6 (sk) * 1991-06-20 2001-12-03 Pfizer Inc. Fluoroalkoxybenzylamínové deriváty heterocyklov obsahujúcich dusík, spôsob ich prípravy, medziprodukty, spôsob prípravy medziproduktov, použitie a farmaceutický prostriedok
EP0687268B1 (en) * 1993-03-04 1998-05-27 Pfizer Inc. Spiroazacyclic derivatives as substance p antagonists
EP0623344B1 (fr) * 1993-05-04 2000-07-26 Ceva Sante Animale Utilisation de la Sélégiline en médecine vetérinaire
IL109646A0 (en) * 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5703065A (en) * 1993-09-17 1997-12-30 Pfizer Inc. Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds
US6083943A (en) * 1993-09-17 2000-07-04 Pfizer Inc Substituted azaheterocyclecarboxylic acid
US5854262A (en) * 1993-10-07 1998-12-29 Pfizer Inc. Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
PE45195A1 (es) * 1994-03-03 1996-01-17 Boehringer Ingelheim Kg Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2229259T3 (es) * 1995-01-12 2005-04-16 Glaxo Group Limited Derivados de piperidina con actividad antagonista de taquiquinina.
US5990125A (en) * 1996-01-19 1999-11-23 Pfizer Inc. NK-1 receptor antagonists for the treatment of cancer
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
AU726745B2 (en) * 1996-10-07 2000-11-16 Merck Sharp & Dohme Limited CNS-penetrant NK-1 receptor antagonists as antidepressant and/or an anti-anxiety agent
CA2275527C (en) * 1996-12-19 2003-09-23 Hoechst Marion Roussel, Inc. Novel heterocyclic substituted pyrrolidine amide derivatives
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
JP4669095B2 (ja) * 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
CA2280309C (en) * 1999-08-13 2007-05-08 William Norton Milgram Use of adrafinil to treat behavioral problems in aged canines
CA2324813A1 (en) * 1999-11-10 2001-05-10 Susan Beth Sobolov-Jaynes Combination treatment for depression and anxiety
US20020049211A1 (en) * 2000-09-06 2002-04-25 Sobolov-Jaynes Susan Beth Combination treatment for depression and anxiety

Also Published As

Publication number Publication date
HUP0401154A2 (hu) 2004-10-28
JP2005504029A (ja) 2005-02-10
US20030139443A1 (en) 2003-07-24
ZA200308991B (en) 2004-11-19
KR20040029375A (ko) 2004-04-06
CA2448722A1 (en) 2003-02-06
CZ200434A3 (cs) 2005-02-16
WO2003009848A1 (en) 2003-02-06
SK252004A3 (sk) 2005-03-04
PL367944A1 (en) 2005-03-07
CN1529600A (zh) 2004-09-15
EP1411946A1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
MXPA03000923A (es) Compuestos de carboxamida y su uso como antagonistas de un receptor 11cby humano.
EP1610753A4 (en) UROTENSIN-II RECEPTOR ANTAGONISTS OF PHENYLENEDIAMINE AND ANTAGONISTS OF CCR-9
IL152700A0 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
NO20032861D0 (no) Heteroarylurea nevropeptid YY5-reseptorantagonister
SI1677623T1 (sl) Ĺ˝veäśilni izdelek za domaäśe ĺ˝ivali
AU2003256709A8 (en) Pet collar leash device
HUP0401643A3 (en) Substituted urea neuropeptide y y5 receptor antagonists, their use and pharmaceutical compositions containing them
IL161329A0 (en) Benzamide and heteroarylamide as p2x7 receptor antagonists
AU149714S (en) Animal puppy chew
AU2002352476A8 (en) Urea derivatives and their use as vanilloid receptor antagonists
IL169336A0 (en) Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
ZA200308147B (en) Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals.
DE60232760D1 (de) Haustierfutter und Tierfutter
GB0203991D0 (en) Feed for fish and use therof
PL367944A1 (en) Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
PL1641787T3 (pl) Podstawione diketopiperazyny i ich zastosowanie jako antagonistów oksytocyny
PL370221A1 (en) 2-oxazolamines and their use as 5-ht2b receptor antagonists
HUP0300470A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
ZA200405282B (en) Hair removal and animal husbandry method.
GB0123820D0 (en) Animal deterrents
FR2843539B1 (fr) Dispositif de maintien de pansement pour les membres des chats et des chiens
GB0109453D0 (en) Feeding horses
GB0202493D0 (en) Dog leash
HUP0300305A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
DE50300915D1 (de) Gerät zur reinigung und pflege von hunden, insbesondere von hundepfoten